Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Harvard Bioscience (HBIO)

Harvard Bioscience (HBIO)
0.3620 -0.0022 (-0.60%) 10:56 ET [NASDAQ]
0.3621 x 4 0.3623 x 7
Realtime by (Cboe BZX)
0.3621 x 4 0.3623 x 7
Realtime - - (-) -
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
0.3600
Day High
0.3781
Open 0.3643
Previous Close 0.3642 0.3642
Volume 68,958 68,958
Avg Vol 339,815 339,815
Stochastic %K 7.01% 7.01%
Weighted Alpha -90.39 -90.39
5-Day Change -0.0336 (-8.49%) -0.0336 (-8.49%)
52-Week Range 0.3500 - 4.0800 0.3500 - 4.0800
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 16,052
  • Shares Outstanding, K 44,074
  • Annual Sales, $ 94,140 K
  • Annual Income, $ -12,410 K
  • EBIT $ -1 M
  • EBITDA $ 7 M
  • 60-Month Beta 1.47
  • Price/Sales 0.18
  • Price/Cash Flow 3.84
  • Price/Book 0.27
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.04
  • Most Recent Earnings $0.06 on 03/12/25
  • Next Earnings Date 05/06/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Computers and Technology
  • INDUSTRY GROUPING Industrial Scientific

Options Overview Details

View History
  • Implied Volatility 62.29% ( -56.95%)
  • Historical Volatility 122.66%
  • IV Percentile 34%
  • IV Rank 8.49%
  • IV High 689.67% on 04/03/25
  • IV Low 4.09% on 08/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 14
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 450
  • Open Int (30-Day) 421

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.04
  • Number of Estimates 1
  • High Estimate -0.04
  • Low Estimate -0.04
  • Prior Year 0.00
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3500 +3.49%
on 04/08/25
Period Open: 0.6361
0.6699 -45.93%
on 04/01/25
-0.2739 (-43.06%)
since 03/21/25
3-Month
0.3500 +3.49%
on 04/08/25
Period Open: 1.9500
1.9700 -81.61%
on 01/23/25
-1.5878 (-81.43%)
since 01/22/25
52-Week
0.3500 +3.49%
on 04/08/25
Period Open: 3.7000
4.0800 -91.12%
on 05/06/24
-3.3378 (-90.21%)
since 04/22/24

Most Recent Stories

More News
Harvard Bioscience Announces CFO Transition

HBIO : 0.3620 (-0.60%)
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

HBIO : 0.3620 (-0.60%)
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results

HBIO : 0.3620 (-0.60%)
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting

HBIO : 0.3620 (-0.60%)
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

HBIO : 0.3620 (-0.60%)
Sidoti Events, LLC's Virtual January Micro-Cap Conference

NEW YORK, NY / ACCESS Newswire / January 21, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day January Micro-Cap Conference...

HBIO : 0.3620 (-0.60%)
FLXS : 35.35 (+10.69%)
RECT : 4.08 (+2.23%)
ALCO : 28.75 (-0.28%)
LCFY : 3.85 (-2.04%)
ABL : 8.38 (+3.97%)
BHR : 1.8650 (+0.81%)
SCWO : 0.2535 (+0.32%)
AMST : 2.07 (+1.47%)
RZLV : 1.4000 (+3.70%)
NNBR : 1.8000 (+5.26%)
SBC : 4.09 (-0.49%)
Harvard Bioscience, Inc. to Participate in the Sidoti Micro Cap Conference

HBIO : 0.3620 (-0.60%)
Harvard Bioscience: Q3 Earnings Snapshot

Harvard Bioscience: Q3 Earnings Snapshot

HBIO : 0.3620 (-0.60%)
Harvard Bioscience Announces Third Quarter 2024 Financial Results

HBIO : 0.3620 (-0.60%)
Harvard Bioscience Schedules Third Quarter 2024 Earnings Conference Call for November 7, 2024 at 8:00 AM ET

HBIO : 0.3620 (-0.60%)

Business Summary

HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.

See More

Key Turning Points

3rd Resistance Point 0.4295
2nd Resistance Point 0.4147
1st Resistance Point 0.3895
Last Price 0.3620
1st Support Level 0.3495
2nd Support Level 0.3347
3rd Support Level 0.3095

See More

52-Week High 4.0800
Fibonacci 61.8% 2.6551
Fibonacci 50% 2.2150
Fibonacci 38.2% 1.7749
Last Price 0.3620
52-Week Low 0.3500

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro